IEQ Capital’s iTeos Therapeutics ITOS Stock Holding History

IEQ Capital’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-45,399	Closed	-$453K	–	1963
2025 Q2	$453K	Buy	45,399 +30,650	+208%	+$247K	﹤0.01%	1208
2025 Q1	$88.1K	Buy	+14,749	New	+$108K	﹤0.01%	1496

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

IEQ Capital's ITOS Position: Q3 2025 in Review

IEQ Capital sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 45,399 shares — an estimated $453K sold.

IEQ Capital first reported a position in ITOS in Q1 2025 and held it in 2 quarters. The position peaked at $453K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

IEQ Capital reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
IEQ Capital sold 45,399 iTeos Therapeutics shares in Q3 2025, an estimated $453K.
IEQ Capital first reported a position in iTeos Therapeutics in Q1 2025 and held it in 2 quarters.
IEQ Capital's iTeos Therapeutics position peaked at $453K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on IEQ Capital's 13F filing for Q3 2025, filed 14 Nov 2025.